首页> 美国卫生研究院文献>other >Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion
【2h】

Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusion

机译:基质金属蛋白酶-2或-9缺失在脑缺血和再灌注早期期间保护出血性转化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

MMP-9 deficiency protected against photochemical thrombosis induced brain hemorrhagic transformation (HT), but it did not protect against tissue plasminogen activator induced brain hemorrhage. The roles of MMP-2 and/or MMP-9 knockout (KO) in mechanical reperfusion induced HT after ischemia have not been investigated. Here we assessed the effects of MMP-2 KO, MMP-9 KO and MMP-2/9 double KO (dKO) in protecting against mechanical reperfusion induced HT and other brain injuries after the early stages of cerebral ischemia in mice of the same genetic background. Middle cerebral artery occlusion (MCAO) was performed in mice. Reperfusion was started at 1 or 1.5 hours after onset of MCAO. All mice were sacrificed 8 hours after MCAO. We found that both pro- and active MMP-2 and MMP-9 levels were significantly elevated in the early ischemic brain. After the early stages of ischemia and reperfusion, the hemorrhagic incidence was reduced in the cortex of MMP-2 KO mice (p < 0.05 vs. WT). The hemorrhagic volume was significantly decreased in the cortexes of MMP-2 and/or -9 knockout mice (MMP-9 KO vs. WT: p < 0.01, MMP-2 KO and dKO vs. WT: p < 0.001). In the basal ganglia, MMP-2 KO and MMP-2/9 dKO mice displayed a remarkable decrease in hemorrhagic volume (p < 0.01 or 0.05 vs. WT), but MMP-9 KOs did not protect against hemorrhage. MMP-2 and/or -9 knockout mice displayed significantly decreased infarction volume in both the cortex and striatum, in addition to improved neurological function (p < 0.001 vs. WT). The results suggested that MMP-2 deficiency and MMP-2 and MMP-9 double deficiency were more protective than MMP-9 deficiency against HT after the early stages of ischemia and reperfusion. These studies increase our understanding of MMP-2 and MMP-9 in HT development and will help to selectively target MMPs to protect the post-ischemic brain from injury and HT.
机译:MMP-9缺乏症免受光化学血栓形成诱导的脑出血性转化(HT),但它没有防止组织纤溶酶原激活剂诱导的脑出血。在缺血缺血后,MMP-2和/或MMP-9敲除(KO)在机械再灌注诱导HT中的作用。在这里,我们评估了MMP-2 KO,MMP-9 KO和MMP-2/9双倍KO(DKO)对抗机械再灌注诱导的HT和其他脑损伤后的脑缺血在同一遗传症小鼠的早期阶段的影响背景。中脑动脉闭塞(MCAO)在小鼠中进行。在MCAO发作后在1或1.5小时开始再灌注。 MCAO后8小时内处死所有小鼠。我们发现,早期缺血性脑中,Pro-和活性MMP-2和MMP-9水平均显着升高。在缺血和再灌注的早期阶段之后,在MMP-2KO小鼠的皮质中降低了出血入射(P <0.05 Vs.wt)。 MMP-2和/或-9敲除小鼠的皮质(MMP-9 KO Vs.wt:P <0.01,MMP-2 KO和DKO与WT:P <0.001)中,出血量显着降低。在基底神经节中,MMP-2 KO和MMP-2/9 DKO小鼠显示出血液腐蚀体积显着降低(P <0.01或0.05 Vs),但MMP-9 KOS没有防止出血。除了改善的神经功能功能外,MMP-2和/或-9敲除小鼠在皮质和纹状体中显示出显着降低的梗死体积(P <0.001 Vs.wt)。结果表明,MMP-2缺乏和MMP-2和MMP-9双缺乏比缺血和再灌注早期对HT的MMP-9缺乏更加保护。这些研究在HT开发中增加了对MMP-2和MMP-9的理解,并有助于选择性地靶向MMP以保护缺血性脑免受伤害和HT保护。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号